Final phase trials to determine the efficacy of a COVID-19 vaccine developed by Maryland based firm Novavax Inc. has begun in US and Mexico,...
efficacy
In a bid to instil confidence among the African-American communities over the safety and efficacy of COVID-19 vaccine, US top infectious disease expert Dr...
Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech...
Japan’s parliament on Wednesday, December 2 approved the bill to provide free COVID-19 vaccination to its 126 million people. The bill received the approval...
Russia on Wednesday said that its vaccine Sputnik V is 92 per cent effective at protecting people from COVID-19 according to the first interim...